Patent details

EP4181920 Title: KAT6 INHIBITOR AND COMBINATIONS FOR BREAST CANCER TREATMENT

Basic Information

Publication number:
EP4181920
PCT Application Number:
EP2021069787
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP217495506
PCT Publication Number:
WO2022013369
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
KAT6 INHIBITOR AND COMBINATIONS FOR BREAST CANCER TREATMENT
French Title of Invention:
INHIBITEURS DE KAT6 ET COMBINAISONS POUR LE TRAITEMENT DU CANCER DU SEIN
German Title of Invention:
KAT6-INHIBITOR UND KOMBINATIONEN ZUR BRUSTKREBSBEHANDLUNG
SPC Number:

Dates

Filing date:
15/07/2021
Grant date:
10/09/2025
EP Publication Date:
24/05/2023
PCT Publication Date:
20/01/2022
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/09/2025
EP B1 Publication Date:
10/09/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/07/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/09/2025
 
 

Name:
CTXT PTY LTD
Address:
305 Grattan Street Parkville, Melbourne, VIC 3000, Australia (AU)

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
10/09/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CHEN, Lei
Address:
United States (US)

2

Name:
FOLLETTIE, Maximillian Todd
Address:
United States (US)

3

Name:
FRUHLING, David Scott
Address:
United States (US)

4

Name:
KUNG, Pei-Pei
Address:
United States (US)

5

Name:
ZHONG, Wenyan
Address:
United States (US)

6

Name:
STUPPLE, Paul Anthony
Address:
Australia (AU)

7

Name:
ARNDT, Kim Timothy
Address:
United States (US)

8

Name:
MAZUREK, Anthony
Address:
United States (US)

9

Name:
TEDESCHI, Philip Michael
Address:
United States (US)

Priority

1

Priority Number:
202063052215 P
Priority Date:
15/07/2020
Priority Country:
United States (US)

2

Priority Number:
202163211044 P
Priority Date:
16/06/2021
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4196; A61K 31/423; A61K 31/506; A61K 31/519; A61K 31/565; A61K 31/7064; A61K 31/18; A61K 45/06; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202537
Publication date:
10/09/2025
Description:
Grant (B1)

2

Issue number:
202542
Publication date:
15/10/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
10/09/2025 Power Of Attorney 1
10/09/2025 Outgoing Correspondence 1